Annual CFI:
-$1.77B+$629.18M(+26.17%)Summary
- As of today, GSK annual cash from investing is -$1.77 billion, with the most recent change of +$629.18 million (+26.17%) on December 31, 2024.
- During the last 3 years, GSK annual cash from investing has risen by +$691.04 million (+28.02%).
- GSK annual cash from investing is now -119.58% below its all-time high of $9.06 billion, reached on December 31, 2015.
Performance
GSK Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
-$824.98M+$755.46M(+47.80%)Summary
- As of today, GSK quarterly cash from investing is -$824.98 million, with the most recent change of +$755.46 million (+47.80%) on June 30, 2025.
- Over the past year, GSK quarterly cash from investing has dropped by -$1.75 billion (-189.22%).
- GSK quarterly cash from investing is now -107.74% below its all-time high of $10.66 billion, reached on March 31, 2015.
Performance
GSK Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$4.87B-$1.75B(-56.12%)Summary
- As of today, GSK TTM cash from investing is -$4.87 billion, with the most recent change of -$1.75 billion (-56.12%) on June 30, 2025.
- Over the past year, GSK TTM cash from investing has dropped by -$5.16 billion (-1765.21%).
- GSK TTM cash from investing is now -152.17% below its all-time high of $9.33 billion, reached on March 31, 2015.
Performance
GSK TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
GSK Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +26.2% | -189.2% | -1765.2% |
| 3Y3 Years | +28.0% | -41.5% | +35.3% |
| 5Y5 Years | +74.5% | -123.2% | -310.0% |
GSK Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +83.7% | -189.2% | +83.5% | -1765.2% | +55.3% |
| 5Y | 5-Year | -166.1% | +83.7% | -189.2% | +83.5% | -278.5% | +55.3% |
| All-Time | All-Time | -119.6% | +87.9% | -107.7% | +93.8% | -152.2% | +74.8% |
GSK Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$824.98M(+47.8%) | -$4.87B(-56.1%) |
| Mar 2025 | - | -$1.58B(-4.7%) | -$3.12B(-74.0%) |
| Dec 2024 | -$1.77B(+26.2%) | -$1.51B(-58.5%) | -$1.79B(>-9900.0%) |
| Sep 2024 | - | -$952.61M(-203.0%) | $9.36M(-96.8%) |
| Jun 2024 | - | $924.65M(+462.8%) | $292.30M(+114.9%) |
| Mar 2024 | - | -$254.86M(-187.2%) | -$1.96B(+17.9%) |
| Dec 2023 | -$2.40B(+77.9%) | $292.18M(+143.6%) | -$2.39B(+22.1%) |
| Sep 2023 | - | -$669.67M(+49.7%) | -$3.07B(+58.6%) |
| Jun 2023 | - | -$1.33B(-94.6%) | -$7.41B(-11.2%) |
| Mar 2023 | - | -$684.07M(-77.7%) | -$6.66B(+38.3%) |
| Dec 2022 | -$10.88B(-341.3%) | -$385.03M(+92.3%) | -$10.79B(+0.8%) |
| Sep 2022 | - | -$5.01B(-758.6%) | -$10.88B(-44.6%) |
| Jun 2022 | - | -$583.22M(+87.9%) | -$7.52B(-4.3%) |
| Mar 2022 | - | -$4.82B(-920.4%) | -$7.21B(-192.9%) |
| Dec 2021 | -$2.47B(-191.8%) | -$472.18M(+71.4%) | -$2.46B(-21.1%) |
| Sep 2021 | - | -$1.65B(-502.8%) | -$2.03B(-84.7%) |
| Jun 2021 | - | -$273.59M(-304.9%) | -$1.10B(-140.4%) |
| Mar 2021 | - | -$67.57M(-59.2%) | $2.73B(+1.6%) |
| Dec 2020 | $2.69B(+138.6%) | -$42.44M(+94.1%) | $2.68B(+15.8%) |
| Sep 2020 | - | -$717.14M(-120.2%) | $2.32B(-6.9%) |
| Jun 2020 | - | $3.55B(+3297.3%) | $2.49B(+236.7%) |
| Mar 2020 | - | -$111.16M(+72.8%) | -$1.82B(+73.5%) |
| Dec 2019 | -$6.95B(+52.4%) | -$408.20M(+25.0%) | -$6.89B(+1.6%) |
| Sep 2019 | - | -$544.16M(+28.3%) | -$7.00B(-3.4%) |
| Jun 2019 | - | -$758.83M(+85.3%) | -$6.77B(+64.9%) |
| Mar 2019 | - | -$5.18B(-894.4%) | -$19.30B(-31.2%) |
| Dec 2018 | -$14.62B(-646.3%) | -$520.62M(-67.2%) | -$14.72B(-0.2%) |
| Sep 2018 | - | -$311.47M(+97.7%) | -$14.69B(+1.9%) |
| Jun 2018 | - | -$13.29B(-2142.0%) | -$14.98B(-559.9%) |
| Mar 2018 | - | -$592.81M(-20.5%) | -$2.27B(-16.2%) |
| Dec 2017 | -$1.96B(-5.5%) | -$491.96M(+18.2%) | -$1.95B(-16.4%) |
| Sep 2017 | - | -$601.40M(-3.1%) | -$1.68B(-28.5%) |
| Jun 2017 | - | -$583.43M(-111.1%) | -$1.30B(-12.3%) |
| Mar 2017 | - | -$276.33M(-27.9%) | -$1.16B(+37.4%) |
| Dec 2016 | -$1.86B(-120.5%) | -$216.07M(+5.7%) | -$1.86B(+20.4%) |
| Sep 2016 | - | -$229.03M(+48.0%) | -$2.33B(+2.0%) |
| Jun 2016 | - | -$440.40M(+54.6%) | -$2.38B(+6.0%) |
| Mar 2016 | - | -$970.28M(-40.1%) | -$2.53B(-127.8%) |
| Dec 2015 | $9.06B(+580.4%) | -$692.57M(-150.1%) | $9.10B(-0.4%) |
| Sep 2015 | - | -$276.89M(+53.3%) | $9.14B(+1.2%) |
| Jun 2015 | - | -$593.12M(-105.6%) | $9.04B(-3.1%) |
| Mar 2015 | - | $10.66B(+1736.7%) | $9.33B(+408.9%) |
| Dec 2014 | -$1.89B(-754.5%) | -$651.62M(-70.2%) | -$3.02B(-895.0%) |
| Sep 2014 | - | -$382.84M(-27.5%) | $379.90M(+845.3%) |
| Jun 2014 | - | -$300.18M(+82.2%) | -$50.97M(+89.9%) |
| Mar 2014 | - | -$1.69B(-161.3%) | -$505.85M(-129.1%) |
| Dec 2013 | -$220.83M(+94.9%) | $2.75B(+437.8%) | -$220.83M(+93.5%) |
| Sep 2013 | - | -$813.71M(-7.8%) | -$3.39B(+47.0%) |
| Jun 2013 | - | -$755.06M(+46.1%) | -$6.39B(-8.1%) |
| Mar 2013 | - | -$1.40B(-234.7%) | -$5.91B(-37.0%) |
| Dec 2012 | -$4.31B(-1049.4%) | -$418.37M(+89.0%) | -$4.31B(+8.4%) |
| Sep 2012 | - | -$3.81B(-1266.8%) | -$4.71B(-257.0%) |
| Jun 2012 | - | -$279.02M(-242.1%) | -$1.32B(+10.8%) |
| Mar 2012 | - | $196.39M(+124.2%) | -$1.48B(-292.4%) |
| Dec 2011 | -$375.12M | -$812.40M(-91.7%) | -$376.72M(+28.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | -$423.83M(+3.3%) | -$524.48M(+40.4%) |
| Jun 2011 | - | -$438.31M(-133.8%) | -$880.40M(+29.3%) |
| Mar 2011 | - | $1.30B(+235.2%) | -$1.24B(+59.5%) |
| Dec 2010 | -$3.08B(+52.4%) | -$960.16M(-23.1%) | -$3.08B(+6.6%) |
| Sep 2010 | - | -$779.75M(+2.8%) | -$3.29B(+48.0%) |
| Jun 2010 | - | -$802.49M(-50.3%) | -$6.34B(-6.0%) |
| Mar 2010 | - | -$533.79M(+54.7%) | -$5.98B(+7.5%) |
| Dec 2009 | -$6.47B(-47.2%) | -$1.18B(+69.2%) | -$6.47B(+5.7%) |
| Sep 2009 | - | -$3.83B(-758.7%) | -$6.86B(-87.3%) |
| Jun 2009 | - | -$445.47M(+56.2%) | -$3.66B(+23.1%) |
| Mar 2009 | - | -$1.02B(+35.1%) | -$4.76B(-8.5%) |
| Dec 2008 | -$4.39B(+32.9%) | -$1.57B(-149.2%) | -$4.39B(+23.1%) |
| Sep 2008 | - | -$629.43M(+59.3%) | -$5.71B(+4.1%) |
| Jun 2008 | - | -$1.55B(-139.5%) | -$5.95B(-15.4%) |
| Mar 2008 | - | -$646.17M(+77.6%) | -$5.16B(+21.4%) |
| Dec 2007 | -$6.54B(-93.6%) | -$2.89B(-231.6%) | -$6.57B(-27.4%) |
| Sep 2007 | - | -$871.36M(-15.6%) | -$5.15B(+1.8%) |
| Jun 2007 | - | -$753.70M(+63.2%) | -$5.25B(-5.4%) |
| Mar 2007 | - | -$2.05B(-38.6%) | -$4.98B(-48.5%) |
| Dec 2006 | -$3.38B(+5.2%) | -$1.48B(-53.1%) | -$3.35B(+21.8%) |
| Sep 2006 | - | -$965.95M(-98.3%) | -$4.29B(-9.8%) |
| Jun 2006 | - | -$487.13M(-15.3%) | -$3.91B(+2.1%) |
| Mar 2006 | - | -$422.34M(+82.5%) | -$3.99B(-11.7%) |
| Dec 2005 | -$3.56B(-76.2%) | -$2.42B(-313.5%) | -$3.57B(-137.6%) |
| Sep 2005 | - | -$584.22M(-2.7%) | -$1.50B(+22.4%) |
| Jun 2005 | - | -$569.01M(>-9900.0%) | -$1.94B(-11.5%) |
| Mar 2005 | - | -$3.80M(+98.9%) | -$1.74B(+13.1%) |
| Dec 2004 | -$2.02B(-31.7%) | -$346.65M(+66.0%) | -$2.00B(+14.6%) |
| Sep 2004 | - | -$1.02B(-176.0%) | -$2.34B(-38.3%) |
| Jun 2004 | - | -$369.13M(-38.5%) | -$1.69B(-8.6%) |
| Mar 2004 | - | -$266.51M(+61.3%) | -$1.56B(-2.6%) |
| Dec 2003 | -$1.54B(+10.2%) | -$688.64M(-86.2%) | -$1.52B(+4.4%) |
| Sep 2003 | - | -$369.76M(-57.8%) | -$1.59B(+1.6%) |
| Jun 2003 | - | -$234.34M(-3.0%) | -$1.62B(+4.8%) |
| Mar 2003 | - | -$227.59M(+70.0%) | -$1.70B(+0.9%) |
| Dec 2002 | -$1.71B(+51.2%) | -$758.43M(-91.6%) | -$1.71B(+24.8%) |
| Sep 2002 | - | -$395.77M(-25.0%) | -$2.28B(+14.5%) |
| Jun 2002 | - | -$316.51M(-29.8%) | -$2.66B(-21.7%) |
| Mar 2002 | - | -$243.86M(+81.6%) | -$2.19B(+37.4%) |
| Dec 2001 | -$3.51B(-788.3%) | -$1.32B(-69.3%) | -$3.50B(-20.3%) |
| Sep 2001 | - | -$781.24M(-592.9%) | -$2.91B(-54.1%) |
| Jun 2001 | - | $158.51M(+110.2%) | -$1.89B(-200.5%) |
| Mar 2001 | - | -$1.55B(-111.7%) | -$628.23M(+14.4%) |
| Dec 2000 | -$394.78M(+80.7%) | -$733.60M(-405.1%) | -$733.60M(>-9900.0%) |
| Sep 2000 | - | $240.46M(-83.0%) | $0.00(+100.0%) |
| Jun 2000 | - | $1.42B(+185.5%) | -$240.46M(+85.5%) |
| Mar 2000 | - | -$1.66B | -$1.66B |
| Dec 1999 | -$2.05B(-113.7%) | - | - |
| Dec 1998 | -$959.56M(-134.4%) | - | - |
| Dec 1997 | -$409.41M(-435.5%) | - | - |
| Dec 1996 | -$76.45M(+99.0%) | - | - |
| Dec 1995 | -$7.56B(-470.7%) | - | - |
| Jun 1994 | $2.04B(+247.9%) | - | - |
| Jun 1993 | -$1.38B(-111.6%) | - | - |
| Jun 1992 | -$652.10M(+43.2%) | - | - |
| Jun 1991 | -$1.15B | - | - |
FAQ
- What is GSK plc annual cash from investing?
- What is the all-time high annual cash from investing for GSK plc?
- What is GSK plc annual cash from investing year-on-year change?
- What is GSK plc quarterly cash from investing?
- What is the all-time high quarterly cash from investing for GSK plc?
- What is GSK plc quarterly cash from investing year-on-year change?
- What is GSK plc TTM cash from investing?
- What is the all-time high TTM cash from investing for GSK plc?
- What is GSK plc TTM cash from investing year-on-year change?
What is GSK plc annual cash from investing?
The current annual cash from investing of GSK is -$1.77B
What is the all-time high annual cash from investing for GSK plc?
GSK plc all-time high annual cash from investing is $9.06B
What is GSK plc annual cash from investing year-on-year change?
Over the past year, GSK annual cash from investing has changed by +$629.18M (+26.17%)
What is GSK plc quarterly cash from investing?
The current quarterly cash from investing of GSK is -$824.98M
What is the all-time high quarterly cash from investing for GSK plc?
GSK plc all-time high quarterly cash from investing is $10.66B
What is GSK plc quarterly cash from investing year-on-year change?
Over the past year, GSK quarterly cash from investing has changed by -$1.75B (-189.22%)
What is GSK plc TTM cash from investing?
The current TTM cash from investing of GSK is -$4.87B
What is the all-time high TTM cash from investing for GSK plc?
GSK plc all-time high TTM cash from investing is $9.33B
What is GSK plc TTM cash from investing year-on-year change?
Over the past year, GSK TTM cash from investing has changed by -$5.16B (-1765.21%)